IQVIA (NYSE:IQV) Earns “Equal Weight” Rating from Barclays
IQVIA (NYSE:IQV – Get Free Report)‘s stock had its “equal weight” rating reissued by stock analysts at Barclays in a report released on Thursday, MarketBeat reports. They presently have a $170.00 target price on the medical research company’s stock, down from their previous target price of $235.00. Barclays‘s target price would indicate a potential upside […]
IQVIA (NYSE:IQV – Get Free Report)‘s stock had its “equal weight” rating reissued by stock analysts at Barclays in a report released on Thursday, MarketBeat reports. They presently have a $170.00 target price on the medical research company’s stock, down from their previous target price of $235.00. Barclays‘s target price would indicate a potential upside […]
